Device Trial Radar · NCT00905645
Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study
Last checked: Nov 20, 2026Latest source record: Jan 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,788
Actual
Start
Nov 2002
Primary completion
Dec 2018
Study completion Dec 2018
Sponsor
- Lead sponsor
- Tiger Biosciences, LLC.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 20, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary augmentation, primary reconstruction, and/or revision of the female breast.
Conditions
- Breast Augmentation
- Breast Reconstruction
- Breast Revision
Interventions
Silimed Gel-Filled Mammary ImplantDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Local ComplicationsTime frame: 10 Years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sientra, Inc.
Santa Barbara, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.